Buchholz M, Scheerman D, Levato R, Wehrens E, Rios A
EMBO Mol Med. 2024; 16(10):2299-2321.
PMID: 39179741
PMC: 11473723.
DOI: 10.1038/s44321-024-00112-3.
Harris M, Savas P, Virassamy B, OMalley M, Kay J, Mueller S
Nat Rev Cancer. 2024; 24(8):554-577.
PMID: 38969810
DOI: 10.1038/s41568-024-00714-6.
Stibbards-Lyle M, Malinovska J, Badawy S, Schedin P, Rinker K
Front Oncol. 2024; 14:1398196.
PMID: 38835377
PMC: 11148378.
DOI: 10.3389/fonc.2024.1398196.
Ramirez-Torres N, Rivas-Ruiz R, Reyes-Lopez A
Cureus. 2023; 15(10):e47578.
PMID: 38022007
PMC: 10666668.
DOI: 10.7759/cureus.47578.
Singh P, Ali S
Cell Insight. 2023; 2(5):100123.
PMID: 37771567
PMC: 10522874.
DOI: 10.1016/j.cellin.2023.100123.
Gestational Breast Cancer - a Review of Outcomes, Pathophysiology, and Model Systems.
Callaway M, Dos Santos C
J Mammary Gland Biol Neoplasia. 2023; 28(1):16.
PMID: 37450228
PMC: 10348943.
DOI: 10.1007/s10911-023-09546-w.
Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.
Lefrere H, Moore K, Floris G, Sanders J, Seignette I, Bismeijer T
Clin Cancer Res. 2023; 29(18):3729-3743.
PMID: 37449970
PMC: 10502474.
DOI: 10.1158/1078-0432.CCR-22-3645.
Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential.
Wilson B, Shen Q, Cescon D, Reedijk M
Front Genet. 2023; 14:1086163.
PMID: 37065483
PMC: 10095561.
DOI: 10.3389/fgene.2023.1086163.
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers.
Ogony J, Hoskin T, Stallings-Mann M, Winham S, Brahmbhatt R, Arshad M
Breast Cancer Res Treat. 2022; 197(2):277-285.
PMID: 36380012
PMC: 10168666.
DOI: 10.1007/s10549-022-06786-y.
Breast cancers co-opt normal mechanisms of tolerance to promote immune evasion and metastasis.
Crump L, Kines K, Richer J, Lyons T
Am J Physiol Cell Physiol. 2022; 323(5):C1475-C1495.
PMID: 36189970
PMC: 9662806.
DOI: 10.1152/ajpcell.00189.2022.
The relationship between tobacco and breast cancer incidence: A systematic review and meta-analysis of observational studies.
He Y, Si Y, Li X, Hong J, Yu C, He N
Front Oncol. 2022; 12:961970.
PMID: 36185316
PMC: 9520920.
DOI: 10.3389/fonc.2022.961970.
Combining Immune-Related Genes For Delineating the Extracellular Matrix and Predicting Hormone Therapy and Neoadjuvant Chemotherapy Benefits In Breast Cancer.
Liu J, Lei B, Yu X, Li Y, Deng Y, Yang G
Front Immunol. 2022; 13:888339.
PMID: 35911730
PMC: 9331652.
DOI: 10.3389/fimmu.2022.888339.
Mapping hormone-regulated cell-cell interaction networks in the human breast at single-cell resolution.
Murrow L, Weber R, Caruso J, McGinnis C, Phong K, Gascard P
Cell Syst. 2022; 13(8):644-664.e8.
PMID: 35863345
PMC: 9590200.
DOI: 10.1016/j.cels.2022.06.005.
The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer: A Nationwide Study by the SMARTSHIP Group.
Park S, Lee J, Yoon J, Kim N, Park S, Youn H
Front Oncol. 2022; 12:889433.
PMID: 35847886
PMC: 9283825.
DOI: 10.3389/fonc.2022.889433.
Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence.
Ogony J, de Bel T, Radisky D, Kachergus J, Thompson E, Degnim A
Breast Cancer Res. 2022; 24(1):45.
PMID: 35821041
PMC: 9275035.
DOI: 10.1186/s13058-022-01541-z.
Serum hormone levels and normal breast histology among premenopausal women.
Sherman M, de Bel T, Heckman M, White L, Ogony J, Stallings-Mann M
Breast Cancer Res Treat. 2022; 194(1):149-158.
PMID: 35503494
PMC: 9869890.
DOI: 10.1007/s10549-022-06600-9.
The Mammary Gland: Basic Structure and Molecular Signaling during Development.
Biswas S, Banerjee S, Baker G, Kuo C, Chowdhury I
Int J Mol Sci. 2022; 23(7).
PMID: 35409243
PMC: 8998991.
DOI: 10.3390/ijms23073883.
The Role of Extracellular Matrix Proteins in Breast Cancer.
Lepucki A, Orlinska K, Mielczarek-Palacz A, Kabut J, Olczyk P, Komosinska-Vassev K
J Clin Med. 2022; 11(5).
PMID: 35268340
PMC: 8911242.
DOI: 10.3390/jcm11051250.
Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential.
Vallone S, Garcia Sola M, Schere-Levy C, Meiss R, Hermida G, Chodosh L
Dis Model Mech. 2022; 15(3).
PMID: 35044452
PMC: 8990024.
DOI: 10.1242/dmm.049286.
Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013.
Vohra S, Walens A, Hamilton A, Sherman M, Schedin P, Nichols H
Cancer Epidemiol Biomarkers Prev. 2021; 31(3):561-568.
PMID: 34810211
PMC: 8901538.
DOI: 10.1158/1055-9965.EPI-21-0940.